There is no diagnostic test for MSA, but a neurologist usually suspects the diagnosis based on a patient's rapidly progressive clinical course and neurologic examination. Early in the disease, it can ...

Background Multiple system atrophy (MSA) is a progressive neurodegenerative disorder of unknown etiology, manifesting as combination of parkinsonism, cerebellar syndrome and dysautonomia. Disease ...

ATH434 is a Disease Modifying Drug Candidate Targeting Alpha-Synuclein and Iron in Parkinsonian Disorders –– Topline Data Expected in Early ...

With the last patient visit behind us ... Multiple System Atrophy (MSA) is a rare, neurodegenerative disease characterized by failure of the autonomic nervous system and impaired movement.

MSA is divided into MSA-C (cerebellar type) which has more symptoms of ataxia (incoordination) and MSA-P (parkinsonian type) which has more parkinsonian symptoms but is relatively unresponsive to the ...

("Alterity” or "the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that the last patient in the ATH434-201 ...